Dose Finding Study of Pegylated-P-Interferon-alpha-2b(P1101) in Treatment-Naive Subjects With Hepatitis C Virus Genotype 1 Infection
Clinical trial NCT01587586 · COMPLETED
Trial details
- NCT number
- NCT01587586
- Sponsor
- PharmaEssentia
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-10-18
- Primary completion
- 2016-11-22
- Enrollment
- 107
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.